{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:12:15Z","timestamp":1753891935814,"version":"3.41.2"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T00:00:00Z","timestamp":1642118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Graft-vs. -host disease (GvHD) is a serious and complex immunological complication of haematopoietic stem cell transplantation (HSCT) and is associated with prolonged immunodeficiency and non-relapse mortality. Standard treatment of chronic GvHD comprises steroids in combination with other immunosuppressive agents. Extracorporeal photopheresis (ECP), with its immunomodulatory mechanism, is applied as part of steroid-sparing regimens for chronic GvHD. Immunocompromised, chronically ill patients are at particular risk of severe disease courses of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. T-cell immunity in SARS-CoV-2 infection is well-described but the role of the humoral immune responses is not fully understood. This case report describes a moderate course of SARS-CoV-2 infection in a patient &amp;lt;9 months after HSCT who was suffering from active, severe, chronic GvHD treated with prednisone and ECP. Following HSCT from a matched unrelated donor to cure acute lymphoblastic leukaemia, the 25-year-old male patient experienced multiple infectious complications associated with cytopenia, B-cell dyshomeostasis and autoantibody production followed by development of severe chronic GvHD thereafter at day +212. The steroid-sparing treatment plan consisted of supportive care, topical treatment, prednisone and ECP. He was diagnosed with SARS-CoV-2 infection at day +252, experiencing loss of smell and taste as well as a cough. The patient's oxygen saturation was between 94 and 97% on room air, and computed tomography images showed evolution of typical of SARS-CoV-2 infiltrates. In addition to cytopenia and immune dyshomeostasis, laboratory tests confirmed macrophage activating syndrome, transaminitis and Epstein-Barr virus viraemia. At that time, anti-SARS-CoV-2 monoclonal antibodies were not available in Austria and remdesivir seemed contraindicated. Surprisingly, despite severe lymphopenia the patient developed SARS-CoV-2-specific antibodies within 15 days, which was followed by clearance of SARS-CoV-2 and EBV with resolution of symptoms. Thereafter, parameters of immune dysregulation such as lymphopenia and B-cell dyshomeostasis, the latter characterised by elevated CD21<jats:sup>low<\/jats:sup> B cells and autoantibody expression, normalised. Moreover, we observed complete response of active chronic GvHD to treatment.<\/jats:p>","DOI":"10.3389\/fped.2021.775318","type":"journal-article","created":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T05:54:16Z","timestamp":1642139656000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["SARS-CoV-2 Infection and Active, Multiorgan, Severe cGVHD After HSCT for Adolescent ALL: More Luck Than Understanding? A Case Report"],"prefix":"10.3389","volume":"9","author":[{"given":"Natalia","family":"Zubarovskaya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Hofer-Popow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Idzko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oskar A.","family":"Haas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Lawitschka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,1,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"504.e1","DOI":"10.1016\/j.jtct.2020.12.027","article-title":"Epidemiology and treatment of chronic graft-versus-host disease post-allogeneic hematopoietic cell transplantation: a US claims analysis","volume":"27","author":"Bachier","year":"2021","journal-title":"Transplant Cell Ther."},{"key":"B2","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.jtct.2021.02.035","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. the 2020 Etiology and Prevention Working Group report","volume":"27","author":"Williams","year":"2021","journal-title":"Transplant Cell Ther."},{"key":"B3","doi-asserted-by":"publisher","first-page":"151","DOI":"10.24875\/AIDSRev.20000052","article-title":"The risk and impact of COVID-19 pandemic on immunosuppressed patients: cancer, HIV, and solid organ transplant recipients","volume":"22","author":"Mohammed","year":"2020","journal-title":"AIDS Rev."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1038\/s41409-020-0919-0","article-title":"The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy","volume":"55","author":"Ljungman","year":"2020","journal-title":"Bone Marrow Transplant."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1038\/s41375-021-01302-5","article-title":"COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey","volume":"35","author":"Ljungman","year":"2021","journal-title":"Leukemia."},{"key":"B6","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/imm.13262","article-title":"T-cell responses and therapies against SARS-CoV-2 infection","volume":"162","author":"Toor","year":"2021","journal-title":"Immunology."},{"key":"B7","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.bbmt.2007.10.009","article-title":"Elevated numbers of immature\/transitional CD21- B lymphocytes and deficiency of memory CD27+ B cells identify patients with active chronic graft-versus-host disease","volume":"14","author":"Greinix","year":"2008","journal-title":"Biol Blood Marrow Transplant."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1182\/blood-2010-07-295766","article-title":"Significant differences in B-cell subpopulations characterize patients with chronic graft-versus-host disease-associated dysgammaglobulinemia","volume":"117","author":"Kuzmina","year":"2011","journal-title":"Blood."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.3389\/fimmu.2019.01879","article-title":"National Institutes of Health-defined chronic graft-vs-host disease in pediatric hematopoietic stem cell transplantation patients correlates with parameters of long-term immune reconstitution","volume":"10","author":"Lawitschka","year":"2019","journal-title":"Front Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1182\/blood.2019003186","article-title":"Immune profile differences between chronic GVHD and late acute GVHD: results of the ABLE\/PBMTC 1202 studies","volume":"135","author":"Schultz","year":"2020","journal-title":"Blood."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/s41423-020-00542-2","article-title":"Expansion of atypical memory B cells is a prominent feature of COVID-19","volume":"17","author":"Oliviero","year":"2020","journal-title":"Cell Mol Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"20499361211013252","DOI":"10.1177\/20499361211013252","article-title":"A review on recipients of hematopoietic stem cell transplantation patients with COVID-19 infection","volume":"8","author":"Sahu","year":"2021","journal-title":"Ther Adv Infect Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"4612","DOI":"10.1002\/jmv.26982","article-title":"Antibody response to SARS-CoV-2 vaccination is extremely vivacious in subjects with previous SARS-CoV-2 infection","volume":"93","author":"Callegaro","year":"2021","journal-title":"J Med Virol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/sj.bmt.1703389","article-title":"Second hematopoietic stem cell transplantation for the treatment of graft failure, graft rejection or relapse after allogeneic transplantation","volume":"29","author":"Wolff","year":"2002","journal-title":"Bone Marrow Transplant."},{"key":"B15","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/bjh.14190","article-title":"Treatment of graft failure with TNI-based reconditioning and haploidentical stem cells in paediatric patients","volume":"175","author":"Teltschik","year":"2016","journal-title":"Br J Haematol."},{"key":"B16","unstructured":"2021"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e737","DOI":"10.1016\/S2352-3026(20)30251-9","article-title":"Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study","volume":"7","author":"Passamonti","year":"2020","journal-title":"Lancet Haematol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40164-020-00177-z","article-title":"Risk factors and outcome of COVID-19 in patients with hematological malignancies","volume":"9","author":"Pinana","year":"2020","journal-title":"Exp Hematol Oncol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"6656","DOI":"10.1172\/JCI141777","article-title":"Favorable outcomes of COVID-19 in recipients of hematopoietic cell transplantation","volume":"130","author":"Shah","year":"2020","journal-title":"J Clin Invest."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e465","DOI":"10.1097\/HS9.0000000000000465","article-title":"COVID-19 - impact on childhood haematology patients","volume":"4","author":"Wolfs","year":"2020","journal-title":"Hemasphere."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1038\/s41375-020-01019-x","article-title":"COVID-19 infection in hematopoietic cell transplantation: age, time from transplant and steroids matter","volume":"34","author":"Varma","year":"2020","journal-title":"Leukemia."},{"key":"B22","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.healun.2020.03.012","article-title":"COVID-19 illness in native and immunosuppressed states: a clinical-therapeutic staging proposal","volume":"39","author":"Siddiqi","year":"2020","journal-title":"J Heart Lung Transplant."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.virol.2020.08.011","article-title":"The novel coronavirus Disease-2019 (COVID-19): mechanism of action, detection and recent therapeutic strategies","volume":"551","author":"Seyed Hosseini","year":"2020","journal-title":"Virology."},{"key":"B24","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.it.2020.11.002","article-title":"T cells: warriors of SARS-CoV-2 infection","volume":"42","author":"de Candia","year":"2021","journal-title":"Trends Immunol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.humimm.2019.03.003","article-title":"B cells in chronic graft-versus-host disease","volume":"80","author":"McManigle","year":"2019","journal-title":"Hum Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1182\/blood.V58.2.360.360","article-title":"Recovery of antibody production in human allogeneic marrow graft recipients: influence of time posttransplantation, the presence or absence of chronic graft-versus-host disease, and antithymocyte globulin treatment","volume":"58","author":"Witherspoon","year":"1981","journal-title":"Blood."},{"key":"B27","doi-asserted-by":"publisher","first-page":"102597","DOI":"10.1016\/j.autrev.2020.102597","article-title":"Covid-19 and autoimmunity","volume":"19","author":"Ehrenfeld","year":"2020","journal-title":"Autoimmun Rev."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1101\/2020.10.21.20216192","article-title":"Relaxed peripheral tolerance drives broad de novo autoreactivity in severe COVID-19","author":"Woodruff","year":"2021","journal-title":"medRxiv."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1007\/s10067-021-05580-3","article-title":"Anti-phospholipids antibodies and immune complexes in COVID-19 patients: a putative role in disease course for anti-annexin-V antibodies","volume":"40","author":"Cristiano","year":"2021","journal-title":"Clin Rheumatol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"102792","DOI":"10.1016\/j.autrev.2021.102792","article-title":"The SARS-CoV-2 as an instrumental trigger of autoimmunity","volume":"20","author":"Dotan","year":"2021","journal-title":"Autoimmun Rev."},{"key":"B31","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1097\/01.TP.0000109778.39235.F4","article-title":"Reduced risk for extensive chronic graft-versus-host disease in patients receiving transplants with human leukocyte antigen-identical sibling donors given polymerase chain reaction-based preemptive therapy against cytomegalovirus","volume":"77","author":"Larsson","year":"2004","journal-title":"Transplantation."},{"key":"B32","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/j.1365-2141.2004.05254.x","article-title":"Impact of human herpesvirus-6 after haematopoietic stem cell transplantation","volume":"128","author":"Hentrich","year":"2005","journal-title":"Br J Haematol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.bbmt.2018.09.031","article-title":"Characteristics of late fatal infections after allogeneic hematopoietic cell transplantation","volume":"25","author":"Norkin","year":"2019","journal-title":"Biol Blood Marrow Transplant."},{"key":"B34","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.clml.2020.06.014","article-title":"Attenuated novel SARS coronavirus 2 infection in an allogeneic hematopoietic stem cell transplant patient on ruxolitinib","volume":"20","author":"Foss","year":"2020","journal-title":"Clin Lymphoma Myeloma Leuk."},{"key":"B35","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1159\/000508479","article-title":"Extracorporeal photopheresis: a case of immunotherapy ahead of its time","volume":"47","author":"Vieyra-Garcia","year":"2020","journal-title":"Transfus Med Hemother."},{"key":"B36","doi-asserted-by":"publisher","first-page":"10902","DOI":"10.1038\/s41598-021-90351-y","article-title":"Positive Epstein-Barr virus detection in coronavirus disease 2019 (COVID-19) patients","volume":"11","author":"Chen","year":"2021","journal-title":"Sci Rep."},{"key":"B37","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1186\/s13054-020-03384-6","article-title":"Correlation of interleukin-6 with Epstein-Barr virus levels in COVID-19","volume":"24","author":"Lehner","year":"2020","journal-title":"Crit Care."},{"key":"B38","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s11427-020-1643-8","article-title":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury","volume":"63","author":"Liu","year":"2020","journal-title":"Sci China Life Sci."}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2021.775318\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T05:54:21Z","timestamp":1642139661000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2021.775318\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,14]]},"references-count":38,"alternative-id":["10.3389\/fped.2021.775318"],"URL":"https:\/\/doi.org\/10.3389\/fped.2021.775318","relation":{},"ISSN":["2296-2360"],"issn-type":[{"type":"electronic","value":"2296-2360"}],"subject":[],"published":{"date-parts":[[2022,1,14]]},"article-number":"775318"}}